Humanin is a member of a new family of peptides that are encoded by short open reading frames within the mitochondrial genome. It is conserved in animals and is both neuroprotective and cytoprotective. Here we report that in the overexpression of humanin is sufficient to increase lifespan, dependent on . Humanin transgenic mice have many phenotypes that overlap with the worm phenotypes and, similar to exogenous humanin treatment, have increased protection against toxic insults. Treating middle-aged mice twice weekly with the potent humanin analogue HNG, humanin improves metabolic healthspan parameters and reduces inflammatory markers. In multiple species, humanin levels generally decline with age, but here we show that levels are surprisingly stable in the naked mole-rat, a model of negligible senescence. Furthermore, in children of centenarians, who are more likely to become centenarians themselves, circulating humanin levels are much greater than age-matched control subjects. Further linking humanin to healthspan, we observe that humanin levels are decreased in human diseases such as Alzheimer’s disease and MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes). Together, these studies are the first to demonstrate that humanin is linked to improved healthspan and increased lifespan.
About The Expert
Kelvin Yen
Hemal H Mehta
Su-Jeong Kim
YanHe Lue
James Hoang
Noel Guerrero
Jenna Port
Qiuli Bi
Gerardo Navarrete
Sebastian Brandhorst
Kaitlyn Noel Lewis
Junxiang Wan
Ronald Swerdloff
Julie A Mattison
Rochelle Buffenstein
Carrie V Breton
Christina Wang
Valter Longo
Gil Atzmon
Douglas Wallace
Nir Barzilai
Pinchas Cohen
References
PubMed